Stathopoulos P. Ioannis, Liakou G. Chrysoula, Katsalira Aikaterini, Trovas George, Lyritis P. George, Papaioannou A. Nikolaos, Tournis Symeon
OBJECTIVE: The unique pharmacokinetics of bisphosphonates (BPs) in conjunction with their use by an increasing number of women at reproductive age has raised serious concerns about their safety during pregnancy and lactation. Bisphosphonates cross the placenta. Animal studies have shown adverse effects on both the fetus and the mother …